Literature DB >> 27020766

Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014.

Erwin Duizer1, Saskia Rutjes, Ana Maria de Roda Husman, Jack Schijven.   

Abstract

On 6 September 2014, the accidental release of 10(13) infectious wild poliovirus type 3 (WPV3) particles by a vaccine production plant in Belgium was reported. WPV3 was released into the sewage system and discharged directly to a wastewater treatment plant (WWTP) and subsequently into rivers that flowed to the Western Scheldt and the North Sea. No poliovirus was detected in samples from the WWTP, surface waters, mussels or sewage from the Netherlands. Quantitative microbial risk assessment (QMRA) showed that the infection risks resulting from swimming in Belgium waters were above 50% for several days and that the infection risk by consuming shellfish harvested in the eastern part of the Western Scheldt warranted a shellfish cooking advice. We conclude that the reported release of WPV3 has neither resulted in detectable levels of poliovirus in any of the samples nor in poliovirus circulation in the Netherlands. This QMRA showed that relevant data on water flows were not readily available and that prior assumptions on dilution factors were overestimated. A QMRA should have been performed by all vaccine production facilities before starting up large-scale culture of WPV to be able to implement effective interventions when an accident happens.

Entities:  

Keywords:  Poliovirus; QMRA; risk based monitoring

Mesh:

Substances:

Year:  2016        PMID: 27020766     DOI: 10.2807/1560-7917.ES.2016.21.11.30169

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  17 in total

Review 1.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

2.  Diagnostic Assay Development for Poliovirus Eradication.

Authors:  Nancy Gerloff; Hong Sun; Mark Mandelbaum; Chelsea Maher; W Allan Nix; Sohail Zaidi; Shahzad Shaukat; Lerato Seakamela; Uma P Nalavade; Deepa K Sharma; M Steven Oberste; Everardo Vega
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

3.  Polio and Measles Down the Drain: Environmental Enterovirus Surveillance in the Netherlands, 2005 to 2015.

Authors:  Kimberley S M Benschop; Harrie G van der Avoort; Edin Jusic; Harry Vennema; Rob van Binnendijk; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

Review 4.  Progress of polio eradication and containment requirements after eradication.

Authors:  M Steven Oberste
Journal:  Transfusion       Date:  2018-12       Impact factor: 3.157

5.  Poliovirus containment risks and their management.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowsa; Kimberly M Thompson
Journal:  Future Virol       Date:  2018-08-10       Impact factor: 1.831

Review 6.  Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Authors:  P L Lopalco
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

7.  Use of guanidine thiocyanate-based nucleic acid extraction buffers to inactivate poliovirus in potentially infectious materials.

Authors:  Michelle J Honeywood; Stacey Jeffries-Miles; Kimberly Wong; Chelsea Harrington; Cara C Burns; M Steven Oberste; Michael D Bowen; Everardo Vega
Journal:  J Virol Methods       Date:  2021-08-09       Impact factor: 2.623

8.  Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017.

Authors:  Erwin Duizer; Wilhelmina Lm Ruijs; Charlie P van der Weijden; Aura Timen
Journal:  Euro Surveill       Date:  2017-05-25

9.  Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.

Authors:  Michael Famulare; Christian Selinger; Kevin A McCarthy; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  PLoS Biol       Date:  2018-04-27       Impact factor: 8.029

10.  Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.

Authors:  Mami Taniuchi; Michael Famulare; Khalequ Zaman; Md Jashim Uddin; Alexander M Upfill-Brown; Tahmina Ahmed; Parimalendu Saha; Rashidul Haque; Ananda S Bandyopadhyay; John F Modlin; James A Platts-Mills; Eric R Houpt; Mohammed Yunus; William A Petri
Journal:  Lancet Infect Dis       Date:  2017-07-07       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.